Protocol Validation of Dynamometric Measurement of Passive Inter-segmental

Status Recruiting

Clinical Trial Summary

Cerebral palsy (CP) refers to a group of movement and posture disorders responsible for activity limitation due to brain damage that occurs during fetal development or during the first year of a child's life. Given the multitude of treatment options available, the choice of treatment is a key determinant that greatly influences the potential for improvement in motor function. This choice is based in particular on a diagnosis resulting from the comparison of a Clinical Gait Analysis (CGA) and a clinical examination, carried out by a practitioner, aimed at evaluating as accurately as possible the deficiencies present in children with CP. During the latter examination, passive inter-segmental stiffness and spasticity, both limiting factors in the mobility of the child with CP, are assessed. However, there are significant uncertainties in these measurements, which depend, among other things, on the examiner's feelings. The enrichment of this clinical assessment therefore requires the introduction of quantitative and objective measures. Portable dynamometers are increasingly used to measure the resistance of a joint during passive solicitations. Thus, both passive inter-segmental stiffness and spasticity can be characterized using instrumental methods. However, in the majority of studies proposed in the literature, the biomechanical computational model used is not unified with that of the CGA, thus altering the approximation of the parameters measured on the table with those estimated during gait. However, in order to evaluate the extent to which these phenomena occur during gait, it is important to follow the same biomechanical calculation procedure. Thus, our team proposes a new dynamometric measurement protocol for passive inter-segmental stiffness and spasticity adapted to the PC child. Nevertheless, in order to guarantee the reliability of the measurements, manual dynamometric solicitation methods must follow standardized protocols, and their psychometric properties must be defined before they can be used in clinical practice. This is why we wish to study the reliability of this new solution for dynamometric quantification of passive inter-segmental stiffness and spasticity in children with CP.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Cerebral Palsy

Clinical Trial Details

NCT number	NCT04596852
Study type	Interventional
Source	Fondation Ellen Poidatz
Contact	Eric Desailly, PhD
Phone	+33160652765
Email	eric.desailly@fondationpoidatz.com
Status	Recruiting
Phase	N/A
Start date	November 2, 2020
Completion date	November 2, 2024

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05317234` - Genetic Predisposition in Cerebral Palsy	N/A
Recruiting	`NCT05576948` - Natural History of Cerebral Palsy Prospective Study
Completed	`NCT04119063` - Evaluating Wearable Robotic Assistance on Gait	Early Phase 1
Completed	`NCT03264339` - The Small Step Program - Early Intervention for Children With High Risk of Developing Cerebral Palsy	N/A
Completed	`NCT05551364` - Usability and Effectiveness of the ATLAS2030 Exoskeleton in Children With Cerebral Palsy	N/A
Completed	`NCT03902886` - Independent Walking Onset of Children With Cerebral Palsy
Recruiting	`NCT05571033` - Operant Conditioning of the Soleus Stretch Reflex in Adults With Cerebral Palsy	N/A
Not yet recruiting	`NCT04081675` - Compliance in Children With Cerebral Palsy Supplied With AFOs
Completed	`NCT02167022` - Intense Physiotherapies to Improve Function in Young Children With Cerebral Palsy	N/A
Completed	`NCT04012125` - The Effect of Flexible Thoracolumbar Brace on Scoliosis in Cerebral Palsy	N/A
Enrolling by invitation	`NCT05619211` - Piloting Movement-to-Music With Arm-based Sprint-Intensity Interval Training Among Children With Physical Disabilities	Phase 1
Completed	`NCT04489498` - Comparison of Somatometric Characteristics Between Cerebral Palsy and Normal Children, Cross-sectional, Multi Center Study
Completed	`NCT03677193` - Biofeedback-enhanced Interactive Computer-play for Youth With Cerebral Palsy	N/A
Recruiting	`NCT06450158` - Robot-assisted Training in Children With CP	N/A
Completed	`NCT04093180` - Intensive Neurorehabilitation for Cerebral Palsy	N/A
Completed	`NCT02909127` - The Pediatric Eating Assessment Tool
Not yet recruiting	`NCT06377982` - Human Umbilical Cord Blood Infusion in Patients With Cerebral Palsy	Phase 1
Not yet recruiting	`NCT06007885` - Examining Capacity Building of Youth With Physical Disabilities to Pursue Participation Following the PREP Intervention.	N/A
Not yet recruiting	`NCT03183427` - Corpus Callosum Size in Patients With Pineal Cyst	N/A
Active, not recruiting	`NCT03078621` - Bone Marrow-Derived Stem Cell Transplantation for the Treatment of Cerebral Palsy	Phase 1/Phase 2

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Protocol Validation of Dynamometric Measurement of Passive Inter-segmental Stiffness and Spasticity in Children With Cerebral Palsy

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms